Copyright
©The Author(s) 2021.
World J Diabetes. Aug 15, 2021; 12(8): 1267-1281
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1267
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1267
Table 4 Comparison of relative expression levels of adiponectin, leptin, and peroxisome proliferators activated receptor-γ genes in liver tissue of mice in each group (X ± S, 2-ΔΔCt)
Group | n | Adp | LEP | PPARγ |
High dose | 6 | 1.85 ± 0.25a,c | 3.27 ± 0.80a,b,c | 2.96 ± 0.98a |
Medium-high dose | 6 | 2.25 ± 0.37a,c | 2.61 ± 0.62a,b,c | 2.93 ± 0.95a |
Medium dose | 6 | 2.63 ± 0.41a | 1.58 ± 0.48 | 2.56 ± 1.18a |
Medium-low dose | 6 | 3.24 ± 0.99a | 1.47 ± 0.59 | 1.68 ± 0.71 |
Low dose | 6 | 3.38 ± 0.89a | 1.09 ± 0.57 | 1.71 ± 0.24 |
Control | 6 | 1.00 ± 0.00 | 1.00 ± 0.00 | 1.00 ± 0.00 |
F value | 13.38 | 15.16 | 5.61 | |
P value | 0.001 | 0.001 | 0.001 |
- Citation: Alimu A, Abudureman H, Wang YZ, Li MY, Wang JS, Liu ZL. Decabromodiphenyl ether causes insulin resistance and glucose and lipid metabolism disorders in mice. World J Diabetes 2021; 12(8): 1267-1281
- URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1267.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1267